L'SEA Trademark

Trademark Overview

On Monday, January 14, 2019, a trademark application was filed for L'SEA with the United States Patent and Trademark Office. The USPTO has given the L'SEA trademark a serial number of 79252376. The federal status of this trademark filing is REGISTERED as of Tuesday, September 3, 2019. This trademark is owned by Lallemand Pharma AG. The L'SEA trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for oral, nasal, and topical applications in the form of sprays for the prevention and treatment of pathogenic biofilm derived infections; medicinal preparations for the mouth and as sprays; decongestant nasal sprays
l'sea

General Information

Serial Number79252376
Word MarkL'SEA
Filing DateMonday, January 14, 2019
Status700 - REGISTERED
Status DateTuesday, September 3, 2019
Registration Number5847844
Registration DateTuesday, September 3, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Goods and ServicesMedicinal preparations for oral, nasal, and topical applications in the form of sprays for the prevention and treatment of pathogenic biofilm derived infections; medicinal preparations for the mouth and as sprays; decongestant nasal sprays

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLallemand Pharma AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameLallemand Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameLallemand Pharma AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Friday, January 24, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 6, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, January 6, 2020FINAL DISPOSITION PROCESSED
Tuesday, December 3, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 3, 2019REGISTERED-PRINCIPAL REGISTER
Friday, June 28, 2019NOTIFICATION PROCESSED BY IB
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 12, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2019REFUSAL PROCESSED BY IB
Friday, April 26, 2019ASSIGNED TO LIE
Friday, April 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 19, 2019NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, April 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 27, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 26, 2019REFUSAL PROCESSED BY MPU
Tuesday, March 19, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 18, 2019NON-FINAL ACTION WRITTEN
Monday, March 11, 2019ASSIGNED TO EXAMINER
Saturday, March 9, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, March 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 21, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

sprays medicinal preparations nasal biofilm derived infections decongestant mouth pathogenic